Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Novel CSF biomarkers for Alzheimer's disease and mild cognitive impairment.

Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, Pickering E, Kuhn M, Chen Y, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ.

Acta Neuropathol. 2010 Jun;119(6):669-78. doi: 10.1007/s00401-010-0667-0.

2.

Clinical indications for analysis of Alzheimer's disease CSF biomarkers.

Engelborghs S.

Rev Neurol (Paris). 2013 Oct;169(10):709-14. doi: 10.1016/j.neurol.2013.07.024. Review.

PMID:
24016466
3.

Simultaneous analysis of cerebrospinal fluid biomarkers using microsphere-based xMAP multiplex technology for early detection of Alzheimer's disease.

Kang JH, Vanderstichele H, Trojanowski JQ, Shaw LM.

Methods. 2012 Apr;56(4):484-93. doi: 10.1016/j.ymeth.2012.03.023. Review.

PMID:
22503777
4.

[Use of cerebrospinal fluid (CSF) biomarkers for Alzheimer's type dementia: diagnosis in mild cognitive impairment].

Verhey FR, Visser PJ.

Ned Tijdschr Geneeskd. 2013;157(11):A5596. Review. Dutch.

PMID:
23484512
5.

Advances in the detection of Alzheimer's disease-use of cerebrospinal fluid biomarkers.

Sjögren M, Andreasen N, Blennow K.

Clin Chim Acta. 2003 Jun;332(1-2):1-10. Review.

PMID:
12763273
6.

Biomarker discovery for Alzheimer's disease, frontotemporal lobar degeneration, and Parkinson's disease.

Hu WT, Chen-Plotkin A, Arnold SE, Grossman M, Clark CM, Shaw LM, McCluskey L, Elman L, Karlawish J, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ.

Acta Neuropathol. 2010 Sep;120(3):385-99. doi: 10.1007/s00401-010-0723-9. Review.

7.
8.

How many biomarkers to discriminate neurodegenerative dementia?

Sancesario GM, Bernardini S.

Crit Rev Clin Lab Sci. 2015;52(6):314-26. doi: 10.3109/10408363.2015.1051658. Review.

PMID:
26292074
9.

CSF biomarkers in neurodegenerative and vascular dementias.

Llorens F, Schmitz M, Ferrer I, Zerr I.

Prog Neurobiol. 2016 Mar-May;138-140:36-53. doi: 10.1016/j.pneurobio.2016.03.003. Review.

PMID:
27016008
10.

Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.

Aluise CD, Sowell RA, Butterfield DA.

Biochim Biophys Acta. 2008 Oct;1782(10):549-58. doi: 10.1016/j.bbadis.2008.07.008. Review.

11.

Do CSF Biomarkers Predict Progression to Cognitive Impairment in Parkinson's disease patients? A Systematic Review.

Leaver K, Poston KL.

Neuropsychol Rev. 2015 Dec;25(4):411-23. doi: 10.1007/s11065-015-9307-8. Review.

12.

Role of cerebrospinal fluid and plasma biomarkers in the diagnosis of neurodegenerative disorders and mild cognitive impairment.

Gonzalez-Cuyar LF, Sonnen JA, Montine KS, Keene CD, Montine TJ.

Curr Neurol Neurosci Rep. 2011 Oct;11(5):455-63. doi: 10.1007/s11910-011-0212-0. Review.

13.

Cerebrospinal fluid biomarkers in mild cognitive impairment and dementia.

Sonnen JA, Montine KS, Quinn JF, Breitner JC, Montine TJ.

J Alzheimers Dis. 2010;19(1):301-9. doi: 10.3233/JAD-2010-1236. Review.

14.

Rethinking on the concept of biomarkers in preclinical Alzheimer's disease.

Berti V, Polito C, Lombardi G, Ferrari C, Sorbi S, Pupi A.

Neurol Sci. 2016 May;37(5):663-72. doi: 10.1007/s10072-016-2477-1. Review.

PMID:
26792010
15.

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH.

Alzheimers Dement. 2011 May;7(3):270-9. doi: 10.1016/j.jalz.2011.03.008.

16.

Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.

Pan Y, Liu R, Terpstra E, Wang Y, Qiao F, Wang J, Tong Y, Pan B.

J Alzheimers Dis. 2016;49(1):1-12. doi: 10.3233/JAD-150451. Review.

PMID:
26484912
17.

Biomarkers in dementia: clinical utility and new directions.

Ahmed RM, Paterson RW, Warren JD, Zetterberg H, O'Brien JT, Fox NC, Halliday GM, Schott JM.

J Neurol Neurosurg Psychiatry. 2014 Dec;85(12):1426-34. doi: 10.1136/jnnp-2014-307662. Review.

Items per page

Supplemental Content

Support Center